Total Payments
$26,383
2024 Payments
$3,112
Companies
62
Transactions
940
Medicare Patients
20,541
Medicare Billing
$2.7M
Payment Breakdown by Category
Food & Beverage$19,791 (75.0%)
Travel$6,439 (24.4%)
Education$129.27 (0.5%)
Gifts$24.17 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,791 | 900 | 75.0% |
| Travel and Lodging | $6,439 | 25 | 24.4% |
| Education | $129.27 | 14 | 0.5% |
| Gift | $24.17 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $4,444 | 37 | $0 (2024) |
| Medtronic Vascular, Inc. | $2,700 | 37 | $0 (2020) |
| Abbott Laboratories | $1,996 | 52 | $0 (2024) |
| Amgen Inc. | $1,604 | 91 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,327 | 87 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,269 | 77 | $0 (2024) |
| Edwards Lifesciences Corporation | $1,247 | 22 | $0 (2022) |
| PFIZER INC. | $1,140 | 88 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,022 | 61 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $921.95 | 45 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,112 | 132 | Impulse Dynamics (USA) Inc. ($392.32) |
| 2023 | $2,633 | 108 | ABIOMED ($352.64) |
| 2022 | $4,959 | 115 | BOSTON SCIENTIFIC CORPORATION ($2,828) |
| 2021 | $1,448 | 89 | Janssen Pharmaceuticals, Inc ($356.18) |
| 2020 | $1,535 | 77 | Amgen Inc. ($291.14) |
| 2019 | $3,036 | 110 | Edwards Lifesciences Corporation ($979.24) |
| 2018 | $4,201 | 127 | Medtronic Vascular, Inc. ($1,961) |
| 2017 | $5,459 | 182 | Abbott Laboratories ($1,313) |
All Payment Transactions
940 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $3.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/12/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/11/2024 | Medtronic, Inc. | COBALT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $35.22 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 12/11/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $19.87 | General |
| Category: Cardiovascular Device | ||||||
| 12/09/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/06/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.66 | General |
| Category: Cardiovascular | ||||||
| 12/02/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $2.31 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/19/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $37.21 | General |
| Category: Pacemakers | ||||||
| 11/18/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/15/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Cardiology | ||||||
| 11/01/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: CDS broad portfolio offering_CRM | ||||||
| 10/31/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $6.12 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/30/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $29.36 | General |
| Category: Cardiovascular Device | ||||||
| 10/28/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/23/2024 | Abbott Laboratories | PRESSUREWIRE (Device) | Food and Beverage | In-kind items and services | $131.11 | General |
| Category: Vascular | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $6.20 | General |
| Category: Cardiovascular | ||||||
| 10/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/09/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/26/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.95 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 43 | 5,456 | 7,441 | $1.8M | $564,848 |
| 2022 | 36 | 4,529 | 6,953 | $1.8M | $617,578 |
| 2021 | 42 | 5,312 | 8,602 | $2.4M | $786,747 |
| 2020 | 39 | 5,244 | 8,527 | $2.3M | $720,266 |
Total Patients
20,541
Total Services
31,523
Medicare Billing
$2.7M
Procedure Codes
171
All Medicare Procedures & Services
171 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 958 | 1,577 | $345,355 | $120,688 | 34.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 253 | 257 | $242,277 | $78,481 | 32.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 868 | 1,133 | $196,952 | $74,394 | 37.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 497 | 522 | $211,321 | $67,244 | 31.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 202 | 821 | $138,456 | $36,363 | 26.3% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 107 | 110 | $71,809 | $21,976 | 30.6% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 31 | 33 | $41,471 | $14,349 | 34.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 79 | 139 | $29,886 | $12,512 | 41.9% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 250 | 254 | $39,365 | $11,700 | 29.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 79 | 84 | $35,206 | $11,061 | 31.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 80 | 85 | $36,761 | $11,026 | 30.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 95 | 95 | $31,658 | $9,937 | 31.4% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 110 | 175 | $23,515 | $8,417 | 35.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 156 | 163 | $40,213 | $8,233 | 20.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 63 | 121 | $17,720 | $7,381 | 41.7% |
| 33340 | Repair of left upper heart chamber with implant with review by radiologist | Facility | 2023 | 12 | 12 | $25,500 | $7,069 | 27.7% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 12 | 12 | $15,378 | $6,775 | 44.1% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 28 | 28 | $20,611 | $6,639 | 32.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 52 | 54 | $15,582 | $5,214 | 33.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 460 | 580 | $23,243 | $5,098 | 21.9% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 11 | 11 | $11,985 | $4,300 | 35.9% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 92 | 92 | $34,216 | $4,205 | 12.3% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 41 | 41 | $13,287 | $3,283 | 24.7% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 18 | 19 | $8,745 | $3,162 | 36.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 40 | 43 | $6,512 | $2,665 | 40.9% |
About Dr. Asim Chohan, M.D
Dr. Asim Chohan, M.D is a Cardiovascular Disease healthcare provider based in Midwest City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1386793156.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Asim Chohan, M.D has received a total of $26,383 in payments from pharmaceutical and medical device companies, with $3,112 received in 2024. These payments were reported across 940 transactions from 62 companies. The most common payment nature is "Food and Beverage" ($19,791).
As a Medicare-enrolled provider, Chohan has provided services to 20,541 Medicare beneficiaries, totaling 31,523 services with total Medicare billing of $2.7M. Data is available for 4 years (2020–2023), covering 171 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Midwest City, OK
- Active Since 01/09/2007
- Last Updated 03/14/2014
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1386793156
Products in Payments
- VersaCross Access Solution (Device) $2,845
- XARELTO (Drug) $1,327
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $1,147
- ClosureFast (Device) $999.17
- ELIQUIS (Drug) $955.03
- Corlanor (Drug) $925.17
- Micra (Device) $923.33
- Impella (Device) $825.87
- GENERAL - VASCULAR ACCESS (Device) $806.97
- ENTRESTO (Drug) $761.81
- BRILINTA (Drug) $681.50
- JARDIANCE (Drug) $629.66
- Repatha (Biological) $607.58
- Visions PV .035 (Device) $564.48
- TURBO POWER (Device) $533.08
- CoreValve Evolut (Device) $475.19
- FARXIGA (Drug) $474.95
- ICDs (Device) $444.17
- VERQUVO (Drug) $431.10
- LifeVest (Device) $394.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.